Pranesh K. Barua

Array ( [id] => 9113336 [patent_doc_number] => 08569509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Thiazole-4-carboxylic acid esters and thioesters as plant protection agents' [patent_app_type] => utility [patent_app_number] => 12/990358 [patent_app_country] => US [patent_app_date] => 2009-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51096 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007981 [patent_doc_number] => 20110060012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => '4-[3-(ARYLOXY)BENZYLIDENE]-3-METHYL PIPERIDINE 5-MEMBERED ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/936946 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19739 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060012.pdf [firstpage_image] =>[orig_patent_app_number] => 12936946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007976 [patent_doc_number] => 20110060007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1' [patent_app_type] => utility [patent_app_number] => 12/991016 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19941 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060007.pdf [firstpage_image] =>[orig_patent_app_number] => 12991016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987821 [patent_doc_number] => 20110098476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'PROCESS FOR PREPARING BIS(THIOHYDRAZIDE AMIDES)' [patent_app_type] => utility [patent_app_number] => 12/934903 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9488 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098476.pdf [firstpage_image] =>[orig_patent_app_number] => 12934903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458770 [patent_doc_number] => 20090258922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'COMPOUND EXHIBITING PGD2 RECEPTOR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/413503 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258922.pdf [firstpage_image] =>[orig_patent_app_number] => 12413503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944868 [patent_doc_number] => 20110105488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'SUBSTITUTED PYRROLIDINE AND PIPERIDINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 12/933719 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25151 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105488.pdf [firstpage_image] =>[orig_patent_app_number] => 12933719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142112 [patent_doc_number] => 07687521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity' [patent_app_type] => utility [patent_app_number] => 12/406283 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26570 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687521.pdf [firstpage_image] =>[orig_patent_app_number] => 12406283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026380 [patent_doc_number] => 20110053984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'NOVEL 4-BENZHYDRYLOXY-TETRAALKYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/921030 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053984.pdf [firstpage_image] =>[orig_patent_app_number] => 12921030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8115197 [patent_doc_number] => 08158810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'ALDH-2 inhibitors in the treatment of addiction' [patent_app_type] => utility [patent_app_number] => 12/371398 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39028 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158810.pdf [firstpage_image] =>[orig_patent_app_number] => 12371398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323271 [patent_doc_number] => 20100113792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'BENZYLPIPERIZINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/597942 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34362 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113792.pdf [firstpage_image] =>[orig_patent_app_number] => 12597942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8592166 [patent_doc_number] => 08350042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Antiviral compounds for the treatment of HCV infection' [patent_app_type] => utility [patent_app_number] => 12/865385 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 14310 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44547 [patent_doc_number] => 07777041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => '2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof' [patent_app_type] => utility [patent_app_number] => 12/360568 [patent_app_country] => US [patent_app_date] => 2009-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21639 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777041.pdf [firstpage_image] =>[orig_patent_app_number] => 12360568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355577 [patent_doc_number] => 20090186921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'AZACYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/355737 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 50688 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186921.pdf [firstpage_image] =>[orig_patent_app_number] => 12355737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624513 [patent_doc_number] => 08003811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Nitric oxide donor compounds' [patent_app_type] => utility [patent_app_number] => 12/744168 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9861 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003811.pdf [firstpage_image] =>[orig_patent_app_number] => 12744168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189383 [patent_doc_number] => 08183257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Muscarinic acetylcholine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/353436 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24475 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183257.pdf [firstpage_image] =>[orig_patent_app_number] => 12353436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003031 [patent_doc_number] => 20110118248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Heteroaryl sulfonamides and CCR2/CCR9' [patent_app_type] => utility [patent_app_number] => 12/309314 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 116600 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118248.pdf [firstpage_image] =>[orig_patent_app_number] => 12309314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499272 [patent_doc_number] => 20100286203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PHARMACEUTICALLY ACCEPTABLE SALTS OF 2--2H-INDAZOLE-7-CARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 12/811922 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18501 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286203.pdf [firstpage_image] =>[orig_patent_app_number] => 12811922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9376016 [patent_doc_number] => 08680281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1' [patent_app_type] => utility [patent_app_number] => 12/811577 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47626 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279355 [patent_doc_number] => 20090131487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'GROWTH FACTOR-BINDING COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/338588 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8465 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131487.pdf [firstpage_image] =>[orig_patent_app_number] => 12338588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441997 [patent_doc_number] => 20090093636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/334124 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9373 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093636.pdf [firstpage_image] =>[orig_patent_app_number] => 12334124 [rel_patent_id] =>[rel_patent_doc_number] =>)